Imricor (IMR) is held by 2 ASX ETFs. Over the last 3 months it fell 17.4%: on $10,000, −$1737. We explain 3 big moves in that time.
About IMR
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$520.0m
- Held by2 ETFs
- Big moves3 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +3.1%peak +6.7%18 Sep 2026· Regulatory
Imricor Medical Systems rose as investor interest built ahead of an anticipated US regulatory approval, supported by a new securities quotation filing that signals a recent capital raise settling into the market.
- −0.5%peak +2.4%14 Aug 2026· Regulatory
Imricor Medical Systems rose after news it submitted its final 510(k) devices, bringing its full US FDA product platform closer to regulatory clearance.
- +5.1%13 Aug 2026· Contract
Imricor Medical Systems submitted final 510(k) devices, moving its full US FDA product platform closer to commercialization.
Held by 2 ETFs
Of every $10,000 in each fund, how much is in IMR today.
Why did IMR rise 3.1% on 18 Sep 2026?
Imricor
Imricor Medical Systems rose as investor interest built ahead of an anticipated US regulatory approval, supported by a new securities quotation filing that signals a recent capital raise settling into the market.
The Appendix 2A (application for quotation of securities) and Cleansing Notice filed on 17 September indicate a recent placement or capital raise with new shares entering quotation, but these are non-market-sensitive and would not typically drive a 5.68% gain. The most substantive catalyst is the Kalkine news article from 16 September highlighting advancing US regulatory approval, which would be a material value inflection point for a medical devices company like Imricor. The modest volume ratio (1.56x) and sector tailwind (health sector up 0.55%) are consistent with news-driven speculative buying rather than a single definitive announcement, hence medium rather than high confidence.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
Company announcements
News coverage
Sector / macro signals
What it did to the 2 ETFs holding IMR
On $10,000 in each fund, at the weight it holds today